Josh Muntner joins Mesoblast as CFO
Josh was previously head of corporate development and financial transactions at Nasdaq-listed biotechnology company, ContraFect Corporation. With more than 20 years’ experience in healthcare investment banking and corporate finance he has been involved in a wide range of healthcare-related transactions.
Josh served as Managing Director and Co-Head of Healthcare Investment Banking at Janney Montgomery Scott, and spent nine years at Oppenheimer & Co. and its U.S. predecessor, CIBC World Markets. He also served as an investment banker at Prudential Securities.
Mesoblast Chief Executive Dr Silviu Itescu welcomed the appointment of Mr Muntner stating he would bring substantial U.S. corporate finance, transactional and capital markets experience to Mesoblast.